Paszt Attila, Ottlakán Aurél, Ábrahám Szabolcs, Simonka Zsolt, Vas Márton Árpád, Maráz Anikó, . . . Lázár György ifj. (2022). Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer.
Chicago Style (17th ed.) CitationPaszt Attila, et al. Clinical Benefits of Oral Capecitabine over Intravenous 5-fluorouracyl Regimen in Case of Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Rectal Cancer. 2022.
MLA idézésPaszt Attila, et al. Clinical Benefits of Oral Capecitabine over Intravenous 5-fluorouracyl Regimen in Case of Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Rectal Cancer. 2022.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..